
Optimal implant depth (OID) during transcatheter aortic valve replacement (TAVR) occurs about a third of the time, a new study indicates.
The authors, seeking to characterize how the calculation of implant depth for TAVR could impact clinical and hemodynamic outcomes reporting for patients undergoing TAVR with a self-expanding device. The study was undertaken in part because there exist different approaches to OID that may have influence over uniform reporting, coupled with the fact that current updated guidelines (Valve Academic Research Consortium, or VARC-2 guidelines) do not include instructions for implant depth.
Optimizing SE-THV Implantation: important clinical study https://t.co/rqVdHT4TLs and editorial https://t.co/QTt9JvN9EP @GilbertTangMD @JACCJournals @Medtronic #cardiotwitter #TAVR @igeorge1975 pic.twitter.com/CvwmCBkwmd
— RTHahnMD (@hahn_rt) March 17, 2020